Diaceutics PLC Capital Reinvestment Ratio
Diaceutics PLC capital reinvestment ratio. Diaceutics PLC (DXRX) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (GBX696.00K) in capital expenditures (GBX16.00K). See Diaceutics PLC free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Diaceutics PLC (2016–2025)
Capital reinvestment ratio of Diaceutics PLC from 2016 to 2025. This chart tracks Diaceutics PLC's Capital Reinvestment Ratio across 8 annual periods. See Diaceutics PLC free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Diaceutics PLC Capital Reinvestment Ratio by Year (2016–2025)
Diaceutics PLC capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see Diaceutics PLC (DXRX) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | GBX1.50 Million | GBX71.00K | ▼ -99.3% |
| 2024 | 7.12x | GBX651.00K | GBX4.63 Million | ▲ +92.1% |
| 2023 | 3.70x | GBX1.31 Million | GBX4.86 Million | ▲ +287.5% |
| 2022 | 0.96x | GBX5.10 Million | GBX4.87 Million | ▼ -90.3% |
| 2021 | 9.83x | GBX570.00K | GBX5.60 Million | ▼ -60.5% |
| 2020 | 24.88x | GBX253.00K | GBX6.29 Million | ▲ +13390.3% |
| 2017 | 0.18x | GBX1.53 Million | GBX282.92K | ▲ +328.1% |
| 2016 | 0.04x | GBX674.01K | GBX29.03K | — |